Care
In a blog post, the virtual care provider blasts the insurer for paying it less than other providers in California and refusing to process 'every single' out-of-network claim.
Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili's EndeavorRx shows promise for adults with ADHD.
Simon-Kucher's Jan Bordon and Kay Schultze discuss how to encourage uptake for digital health products.
HIMSS23
J29 president and founder Tracy Mills and VP of HHS programs Nick Vass highlight the importance of state and federal agencies collaborating with private companies to better serve population health needs.
Also, Startoon has obtained a US FDA clearance for its wearable recovery tracking device.
Also, Coviu and Alcidion have integrated their remote patient monitoring solutions.
The company reported a larger net loss in the first quarter that included a $330.3 million noncash goodwill impairment charge.
HIMSS23
Toby Eadelman, CTO at AvaSure, discusses how AvaSure's digital offerings can help hospitals optimize their on-site acute-care nurses' workflows amid staffing challenges.
Diabetes management company Hygieia extended its Series B round, and Autonomize AI, a workflow platform for healthcare and life sciences, also announced funding.
The company reported $33.3 million in revenue for Q1 2023 and a net loss of $8.8 million.